» Articles » PMID: 26032020

Abnormal Synaptic Ca(2+) Homeostasis and Morphology in Cortical Neurons of Familial Hemiplegic Migraine Type 1 Mutant Mice

Abstract

Objective: Migraine is among the most common and debilitating neurological conditions. Familial hemiplegic migraine type 1 (FHM1), a monogenic migraine subtype, is caused by gain-of-function of voltage-gated CaV 2.1 calcium channels. FHM1 mice carry human pathogenic mutations in the α1A subunit of CaV 2.1 channels and are highly susceptible to cortical spreading depression (CSD), the electrophysiologic event underlying migraine aura. To date, however, the mechanism underlying increased CSD/migraine susceptibility remains unclear.

Methods: We employed in vivo multiphoton microscopy of the genetically encoded Ca(2+)-indicator yellow cameleon to investigate synaptic morphology and [Ca(2+)]i in FHM1 mice. To study CSD-induced cerebral oligemia, we used in vivo laser speckle flowmetry and multimodal imaging. With electrophysiologic recordings, we investigated the effect of the CaV 2.1 gating modifier tert-butyl dihydroquinone on CSD in vivo.

Results: FHM1 mutations elevate neuronal [Ca(2+)]i and alter synaptic morphology as a mechanism for enhanced CSD susceptibility that we were able to normalize with a CaV 2.1 gating modifier in hyperexcitable FHM1 mice. At the synaptic level, axonal boutons were larger, and dendritic spines were predominantly of the mushroom type, which both provide a structural correlate for enhanced neuronal excitability. Resting neuronal [Ca(2+)]i was elevated in FHM1, with loss of compartmentalization between synapses and neuronal shafts. The percentage of calcium-overloaded neurons was increased. Neuronal [Ca(2+)]i surge during CSD was faster and larger, and post-CSD oligemia and hemoglobin desaturation were more severe in FHM1 brains.

Interpretation: Our findings provide a mechanism for enhanced CSD susceptibility in hemiplegic migraine. Abnormal synaptic Ca(2+) homeostasis and morphology may contribute to chronic neurodegenerative changes as well as enhanced vulnerability to ischemia in migraineurs.

Citing Articles

Unraveling the interplay of neuroinflammatory signaling between parenchymal and meningeal cells in migraine headache.

Dalkara T, Kaya Z, Erdener S J Headache Pain. 2024; 25(1):124.

PMID: 39080518 PMC: 11290240. DOI: 10.1186/s10194-024-01827-x.


PACAP-PAC1 receptor inhibition is effective in opioid induced hyperalgesia and medication overuse headache models.

Bertels Z, Mangutov E, Siegersma K, Cropper H, Tipton A, Pradhan A iScience. 2023; 26(2):105950.

PMID: 36756376 PMC: 9900514. DOI: 10.1016/j.isci.2023.105950.


Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine.

Erdener S, Kaya Z, Dalkara T J Headache Pain. 2021; 22(1):138.

PMID: 34794382 PMC: 8600694. DOI: 10.1186/s10194-021-01353-0.


Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.

Bertels Z, Singh H, Dripps I, Siegersma K, Tipton A, Witkowski W Elife. 2021; 10.

PMID: 33856345 PMC: 8147088. DOI: 10.7554/eLife.63076.


Structural and Functional Brain Changes in Migraine.

Ashina S, Bentivegna E, Martelletti P, Eikermann-Haerter K Pain Ther. 2021; 10(1):211-223.

PMID: 33594593 PMC: 8119592. DOI: 10.1007/s40122-021-00240-5.


References
1.
van den Maagdenberg A, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek F . High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol. 2010; 67(1):85-98. DOI: 10.1002/ana.21815. View

2.
Hasbani M, Hyrc K, Faddis B, Romano C, Goldberg M . Distinct roles for sodium, chloride, and calcium in excitotoxic dendritic injury and recovery. Exp Neurol. 1999; 154(1):241-58. DOI: 10.1006/exnr.1998.6929. View

3.
Ayata C, Shin H, Salomone S, Ozdemir-Gursoy Y, Boas D, Dunn A . Pronounced hypoperfusion during spreading depression in mouse cortex. J Cereb Blood Flow Metab. 2004; 24(10):1172-82. DOI: 10.1097/01.WCB.0000137057.92786.F3. View

4.
Mullner C, Broos L, van den Maagdenberg A, Striessnig J . Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects. J Biol Chem. 2004; 279(50):51844-50. DOI: 10.1074/jbc.M408756200. View

5.
Cao Y, Tsien R . Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission. Proc Natl Acad Sci U S A. 2005; 102(7):2590-5. PMC: 548328. DOI: 10.1073/pnas.0409896102. View